Cargando…
The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites
Human milk oligosaccharides (HMOs) shape the developing infant gut microbiota. In this study, a semi-continuous colon simulator was used to evaluate the effect of 2 HMOs—2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL)—on the composition of infant faecal microbiota and microbial metabolites. Th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304344/ https://www.ncbi.nlm.nih.gov/pubmed/37375055 http://dx.doi.org/10.3390/microorganisms11061553 |
_version_ | 1785065484719226880 |
---|---|
author | Salli, Krista Hirvonen, Johanna Anglenius, Heli Hibberd, Ashley A. Ahonen, Ilmari Saarinen, Markku T. Maukonen, Johanna Ouwehand, Arthur C. |
author_facet | Salli, Krista Hirvonen, Johanna Anglenius, Heli Hibberd, Ashley A. Ahonen, Ilmari Saarinen, Markku T. Maukonen, Johanna Ouwehand, Arthur C. |
author_sort | Salli, Krista |
collection | PubMed |
description | Human milk oligosaccharides (HMOs) shape the developing infant gut microbiota. In this study, a semi-continuous colon simulator was used to evaluate the effect of 2 HMOs—2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL)—on the composition of infant faecal microbiota and microbial metabolites. The simulations were performed with and without a probiotic Bifidobacterium longum subspecies infantis Bi-26 (Bi-26) and compared with a control that lacked an additional carbon source. The treatments with HMOs decreased α-diversity and increased Bifidobacterium species versus the control, but the Bifidobacterium species differed between simulations. The levels of acetic acid and the sum of all short-chain fatty acids (SCFAs) trended toward an increase with 2′-FL, as did lactic acid with 2′-FL and 3-FL, compared with control. A clear correlation was seen between the consumption of HMOs and the increase in SCFAs (−0.72) and SCFAs + lactic acid (−0.77), whereas the correlation between HMO consumption and higher total bifidobacterial numbers was moderate (−0.46). Bi-26 decreased propionic acid levels with 2′-FL. In conclusion, whereas infant faecal microbiota varied between infant donors, the addition of 2′-FL and 3-FL, alone or in combination, increased the relative abundance and numbers Bifidobacterium species in the semi-continuous colon simulation model, correlating with the production of microbial metabolites. These findings may suggest that HMOs and probiotics benefit the developing infant gut microbiota. |
format | Online Article Text |
id | pubmed-10304344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103043442023-06-29 The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites Salli, Krista Hirvonen, Johanna Anglenius, Heli Hibberd, Ashley A. Ahonen, Ilmari Saarinen, Markku T. Maukonen, Johanna Ouwehand, Arthur C. Microorganisms Article Human milk oligosaccharides (HMOs) shape the developing infant gut microbiota. In this study, a semi-continuous colon simulator was used to evaluate the effect of 2 HMOs—2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL)—on the composition of infant faecal microbiota and microbial metabolites. The simulations were performed with and without a probiotic Bifidobacterium longum subspecies infantis Bi-26 (Bi-26) and compared with a control that lacked an additional carbon source. The treatments with HMOs decreased α-diversity and increased Bifidobacterium species versus the control, but the Bifidobacterium species differed between simulations. The levels of acetic acid and the sum of all short-chain fatty acids (SCFAs) trended toward an increase with 2′-FL, as did lactic acid with 2′-FL and 3-FL, compared with control. A clear correlation was seen between the consumption of HMOs and the increase in SCFAs (−0.72) and SCFAs + lactic acid (−0.77), whereas the correlation between HMO consumption and higher total bifidobacterial numbers was moderate (−0.46). Bi-26 decreased propionic acid levels with 2′-FL. In conclusion, whereas infant faecal microbiota varied between infant donors, the addition of 2′-FL and 3-FL, alone or in combination, increased the relative abundance and numbers Bifidobacterium species in the semi-continuous colon simulation model, correlating with the production of microbial metabolites. These findings may suggest that HMOs and probiotics benefit the developing infant gut microbiota. MDPI 2023-06-10 /pmc/articles/PMC10304344/ /pubmed/37375055 http://dx.doi.org/10.3390/microorganisms11061553 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Salli, Krista Hirvonen, Johanna Anglenius, Heli Hibberd, Ashley A. Ahonen, Ilmari Saarinen, Markku T. Maukonen, Johanna Ouwehand, Arthur C. The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites |
title | The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites |
title_full | The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites |
title_fullStr | The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites |
title_full_unstemmed | The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites |
title_short | The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites |
title_sort | effect of human milk oligosaccharides and bifidobacterium longum subspecies infantis bi-26 on simulated infant gut microbiome and metabolites |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304344/ https://www.ncbi.nlm.nih.gov/pubmed/37375055 http://dx.doi.org/10.3390/microorganisms11061553 |
work_keys_str_mv | AT sallikrista theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT hirvonenjohanna theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT angleniusheli theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT hibberdashleya theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT ahonenilmari theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT saarinenmarkkut theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT maukonenjohanna theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT ouwehandarthurc theeffectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT sallikrista effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT hirvonenjohanna effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT angleniusheli effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT hibberdashleya effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT ahonenilmari effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT saarinenmarkkut effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT maukonenjohanna effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites AT ouwehandarthurc effectofhumanmilkoligosaccharidesandbifidobacteriumlongumsubspeciesinfantisbi26onsimulatedinfantgutmicrobiomeandmetabolites |